SuperworthMarker Therapeutics shares outstanding MRKR
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 19.3M
- On a year earlier
- +38.4%
- more shares
Marker Therapeutics had 19.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 38.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 19.3M | +110% |
| FY2024 | 9.2M | +3% |
| FY2023 | 8.9M | +6% |
| FY2022 | 8.4M | +1% |
| FY2021 | 8.3M | +71% |
| FY2020 | 4.9M | +6% |
| FY2019 | 4.6M | +15% |
| FY2018 | 4M | +278% |
| FY2017 | 1.1M | +25% |
| FY2016 | 843.8K | +54% |
| FY2015 | 546.6K | +199% |
| FY2014 | 182.6K | +1399% |
| FY2013 | 12.2K | +97% |
| FY2012 | 6.2K | +51% |
| FY2011 | 4.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 19.3M | +38% | |
| Q1 FY26 | 19.3M | +74% | |
| Q4 FY25 | 19.3M | +110% | |
| Q3 FY25 | 16.8M | +88% | |
| Q2 FY25 | 14M | +56% | |
| Q1 FY25 | 11.1M | +25% | |
| Q4 FY24 | 9.2M | +3% | |
| Q3 FY24 | 8.9M | +1% | |
| Q2 FY24 | 8.9M | +1% | |
| Q1 FY24 | 8.9M | +2% | |
| Q4 FY23 | 8.9M | +6% | |
| Q3 FY23 | 8.8M | +6% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Marker Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.